Organization
Southern Medical University, Guangzhou, China
2 abstracts
Abstract
A multicenter phase I/II trial of induction chemotherapy followed by camrelizumab, apatinib, plus chemotherapy as first-line treatment for extensive-stage small-cell lung cancer.Org: Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, Guangzhou Institute of Respiratory Health, National Center for Respiratory Medicine, State Key Laboratory of Respiratory Diseases, the First Affiliated Hospital of Guangzhou Medical University,
Abstract
APPLICATION OF BIOINFORMATICS ANALYSIS TO IDENTIFY SHARED HUB GENES AND PATHWAYS IN IDIOPATHIC PULMONARY FIBROSIS AND RHEUMATOID ARTHRITIS-ASSOCIATED USUAL INTERSTITIAL PNEUMONIAOrg: The Eighth Affiliated Hospital, Sun Yat-Sen University, Department of Rheumatology, Shenzhen, China, Guangdong Provincial People’s Hospital, Department of Rheumatology, Guangzhou, China, Guangdong Academy of Medical Sciences, Guangzhou, China, Macau University of Science and Technology, Macau, China, Macau University of Science and Technology, Faculty of Chinese Medicine, Macau, China,